| Application no. and date | 17730629.7 (espacenet) (Federated) (European Patent Register), 20170601 | | Patent/reg. no. and date | DK/EP 3464368, 20230628 | | Publication date | 20190410 | | Priority no. and date | US 201662344866 P, 20160602, US 201662382839 P, 20160902 | | EP pub. no. and date |
EP 3464368 20190410 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US,
Seagen Inc., 21823 30th Drive, S.E.
Bothell, WA 98021, US | | Applicant ref. no. | PU278873DKQ | | Inventor | FARSACI, Benedetto, Rt. 206 & Province Line Road
Princeton
New Jersey 08543, US,
JOSEPHSON, Neil, c/o Seattle Genetics Inc.
21823 30th Drive SE
Bothell
Washington 98021, US,
CAO, Anthony, 23707 NE 25th Way
Sammamish
Washington 98074, US,
HEISER, Ryan, 1032 116th Ave SE
Lake Stevens
Washington 98258, US | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ANVENDELSE AF ET ANTI-PD-1-ANTISTOF I KOMBINATION MED ET ANTI-CD30- ANTISTOF I LYMFOMBEHANDLING | | Int. application no. | US2017035521 | | Int. publication no. | WO2017210473 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
